{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,16]],"date-time":"2025-12-16T12:17:10Z","timestamp":1765887430855},"reference-count":0,"publisher":"Begell House","issue":"1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Crit Rev Oncog"],"published-print":{"date-parts":[[2012]]},"DOI":"10.1615\/critrevoncog.v17.i1.30","type":"journal-article","created":{"date-parts":[[2012,7,19]],"date-time":"2012-07-19T09:44:19Z","timestamp":1342691059000},"page":"17-30","source":"Crossref","is-referenced-by-count":21,"title":["Therapeutic Targeting of BCR-ABL: Prognostic Markers of Response and Resistance Mechanism in Chronic Myeloid Leukaemia"],"prefix":"10.1615","volume":"17","author":[{"given":"David T.","family":"Yeung","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Timothy P.","family":"Hughes","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"613","container-title":["Critical Reviews\u2122 in Oncogenesis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/dl.begellhouse.com\/download\/article\/00f0362e63d71e88\/CRO1701-129_final.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,2,15]],"date-time":"2019-02-15T07:57:41Z","timestamp":1550217461000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.dl.begellhouse.com\/journals\/439f422d0783386a,07ff3a573b26d6e9,00f0362e63d71e88.html"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012]]},"references-count":0,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2012]]}},"URL":"https:\/\/doi.org\/10.1615\/critrevoncog.v17.i1.30","relation":{},"ISSN":["0893-9675"],"issn-type":[{"value":"0893-9675","type":"print"}],"subject":[],"published":{"date-parts":[[2012]]}}}